1. Dipòsit Digital de la Universitat de Barcelona
  2. Recerca
  3. ISGlobal - Institut de Salut Global de Barcelona
  4. Articles publicats en revistes (ISGlobal)
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/202127
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMillat Martínez, Pere-
dc.contributor.authorSalman, Sam-
dc.contributor.authorMoore, Brioni R.-
dc.contributor.authorBaró Sastre, Bàrbara-
dc.contributor.authorPage-Sharp, Madhu-
dc.contributor.authorBatty, Kevin T.-
dc.contributor.authorRobinson, Leanne J.-
dc.contributor.authorPomat, William-
dc.contributor.authorKarunajeewa, Harin-
dc.contributor.authorLaman, Moses-
dc.contributor.authorManning, Laurens-
dc.contributor.authorMitjà Villar, Oriol-
dc.contributor.authorBassat Orellana, Quique-
dc.date.accessioned2023-09-21T10:42:35Z-
dc.date.available2023-09-21T10:42:35Z-
dc.date.issued2022-07-06-
dc.identifier.issn1098-6596-
dc.identifier.urihttps://hdl.handle.net/2445/202127-
dc.description.abstractMass drug administration (MDA) with monthly dihydroartemisinin-piperaquine (DHA-PQP) appears useful in malaria control and elimination strategies. Determining the relationship between consecutive piperaquine phosphate (PQP) exposure and its impact on QT interval prolongation is a key safety consideration for MDA campaigns.-
dc.format.extent25 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherAmerican Society for Microbiology-
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1128/aac.00185-22-
dc.relation.ispartofAntimicrobial Agents And Chemotherapy, 2022, vol. 66, num. 8-
dc.relation.urihttps://doi.org/10.1128/aac.00185-22-
dc.rights(c) American Society for Microbiology, 2022-
dc.sourceArticles publicats en revistes (ISGlobal)-
dc.subject.classificationMalària-
dc.subject.classificationFarmacocinètica-
dc.subject.classificationPapua Nova Guinea-
dc.subject.otherMalaria-
dc.subject.otherPharmacokinetics-
dc.subject.otherPapua New Guinea-
dc.titlePiperaquine Pharmacokinetic and Pharmacodynamic Profiles in Healthy Volunteers of Papua New Guinea after Administration of Three-Monthly Doses of Dihydroartemisinin–Piperaquine-
dc.typeinfo:eu-repo/semantics/article-
dc.date.updated2023-09-21T09:56:14Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.idimarina9693224-
dc.identifier.pmid35862743-
Appears in Collections:Articles publicats en revistes (ISGlobal)

Files in This Item:
File Description SizeFormat 
Pere Millat clean manuscript_AAC00185-22_second revision.pdf306.68 kBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.